Clinical Research Directory

Key Inclusion Criteria: 1. Subjects aged ≥ 18 years at screening; 2. Subjects who are willing and able to comply with all scheduled visits, treatment plan, laboratory tests, and other study procedures; 3. Able to provide written informed consent; 4. ECOG performance status score of 0, 1, or 2; 5. Patients with histologically or cytologically confirmed malignant solid tumor; 6. Cancer cachexia documented in medical records; Key Exclusion Criteria: 1. History of hypersensitivity or anaphylactic reaction to any therapeutic or diagnostic monoclonal antibody or molecules composed of monoclonal antibody components; 2. Presence of reversible decreased food intake, as determined by the investigator; 3. Receiving tube feeding or parenteral nutrition (total or partial parenteral nutrition) at screening; 4. Severe gastrointestinal disorders (including esophagitis, gastritis, malabsorption); 5. Cachexia caused by other reasons; 6. Currently participating in another investigational drug study, or receipt of another investigational product ;